Total Payments
$3,473
2024 Payments
$232.31
Companies
47
Transactions
172
Medicare Patients
5,509
Medicare Billing
$420,439
Payment Breakdown by Category
Food & Beverage$3,338 (96.1%)
Consulting$100.00 (2.9%)
Education$34.53 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,338 | 170 | 96.1% |
| Consulting Fee | $100.00 | 1 | 2.9% |
| Education | $34.53 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $459.23 | 34 | $0 (2022) |
| Smith+Nephew, Inc. | $370.85 | 20 | $0 (2024) |
| Melinta Therapeutics, LLC | $347.97 | 14 | $0 (2022) |
| IBSA Pharma Inc. | $269.31 | 13 | $0 (2024) |
| Organogenesis Inc. | $207.95 | 5 | $0 (2023) |
| Bioventus LLC | $183.20 | 7 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $124.57 | 9 | $0 (2019) |
| Nevro Corp. | $108.79 | 3 | $0 (2022) |
| COMSORT, Inc | $100.00 | 1 | $0 (2019) |
| PFIZER INC. | $96.03 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $232.31 | 11 | Smith+Nephew, Inc. ($68.14) |
| 2023 | $431.98 | 20 | IBSA Pharma Inc. ($109.53) |
| 2022 | $636.62 | 28 | Melinta Therapeutics, LLC ($178.41) |
| 2021 | $559.93 | 29 | Horizon Therapeutics plc ($134.91) |
| 2020 | $362.00 | 22 | Horizon Therapeutics plc ($151.24) |
| 2019 | $450.74 | 22 | COMSORT, Inc ($100.00) |
| 2018 | $458.15 | 22 | Organogenesis Inc. ($123.12) |
| 2017 | $340.98 | 18 | Merck Sharp & Dohme Corporation ($71.05) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: ANTIBIOTIC | ||||||
| 11/04/2024 | Bioventus LLC | EXOGEN ULTRASOUND BONE HEALING SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: DEVICES | ||||||
| 10/28/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: ANTIBIOTIC | ||||||
| 09/02/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $22.69 | General |
| Category: Endocrinology | ||||||
| 06/24/2024 | Becton, Dickinson and Company | Venclose Maven Catheter (Device) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Vascular/Oncology | ||||||
| 04/26/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 04/04/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $21.08 | General |
| Category: Endocrinology | ||||||
| 02/12/2024 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: FOOT AND ANKLE | ||||||
| 02/08/2024 | Smith+Nephew, Inc. | VLP FOOT (Device) | Food and Beverage | In-kind items and services | $48.94 | General |
| Category: Extremities & Limb Restoration | ||||||
| 02/06/2024 | Smith+Nephew, Inc. | VLP FOOT (Device) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Extremities & Limb Restoration | ||||||
| 01/04/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 GraftGuide | Food and Beverage | Cash or cash equivalent | $10.80 | General |
| Category: Wound Care | ||||||
| 12/05/2023 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Other Advanced Wound Management | ||||||
| 11/29/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Pharma Products | ||||||
| 11/13/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/17/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $22.69 | General |
| Category: non-opioid analgesic | ||||||
| 10/17/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Neuromodulation | ||||||
| 08/25/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/21/2023 | Smith+Nephew, Inc. | REGRANEX (Drug), COLLAGENASE SANTYL | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Pharma Products | ||||||
| 07/11/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| Category: non-opioid analgesic | ||||||
| 06/13/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/16/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Podiatry | ||||||
| 05/11/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $21.45 | General |
| Category: non-opioid analgesic | ||||||
| 05/01/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $26.91 | General |
| Category: Wound Care | ||||||
| 04/15/2023 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: FOOT AND ANKLE | ||||||
| 03/16/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $23.08 | General |
| Category: non-opioid analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,212 | 1,956 | $260,967 | $97,151 |
| 2022 | 18 | 1,370 | 2,204 | $281,709 | $106,085 |
| 2021 | 18 | 1,525 | 2,505 | $321,125 | $122,726 |
| 2020 | 19 | 1,402 | 2,161 | $260,973 | $94,477 |
Total Patients
5,509
Total Services
8,826
Medicare Billing
$420,439
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 274 | 466 | $67,570 | $28,379 | 42.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 161 | 161 | $28,175 | $11,934 | 42.4% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 126 | 352 | $36,960 | $10,535 | 28.5% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 46 | 127 | $15,875 | $8,758 | 55.2% |
| G0247 | Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following i | Office | 2023 | 114 | 160 | $24,000 | $8,738 | 36.4% |
| 11750 | Permanent removal fingernail or toenail | Office | 2023 | 47 | 57 | $23,865 | $6,327 | 26.5% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 18 | 47 | $11,750 | $4,323 | 36.8% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 140 | 185 | $18,112 | $4,277 | 23.6% |
| G0246 | Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) | Office | 2023 | 105 | 150 | $11,250 | $3,795 | 33.7% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 32 | 61 | $6,915 | $3,226 | 46.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 61 | 78 | $6,630 | $2,989 | 45.1% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 25 | 39 | $2,925 | $1,827 | 62.5% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Office | 2023 | 13 | 17 | $2,975 | $806.98 | 27.1% |
| G0245 | Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that cons | Office | 2023 | 17 | 17 | $2,210 | $801.89 | 36.3% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 11 | 12 | $1,620 | $432.96 | 26.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 22 | 27 | $135.00 | $2.69 | 2.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 282 | 508 | $73,660 | $30,940 | 42.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 210 | 210 | $36,750 | $16,240 | 44.2% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 170 | 432 | $45,360 | $12,476 | 27.5% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 47 | 139 | $17,375 | $9,892 | 56.9% |
| G0247 | Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following i | Office | 2022 | 118 | 167 | $25,050 | $8,852 | 35.3% |
| 11750 | Permanent removal fingernail or toenail | Office | 2022 | 51 | 58 | $23,450 | $6,351 | 27.1% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 146 | 203 | $19,874 | $4,992 | 25.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 70 | 91 | $7,735 | $3,463 | 44.8% |
| G0246 | Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) | Office | 2022 | 100 | 146 | $10,950 | $3,438 | 31.4% |
About Dr. Christopher Anna, DPM
Dr. Christopher Anna, DPM is a Foot & Ankle Surgery healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144262148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Anna, DPM has received a total of $3,473 in payments from pharmaceutical and medical device companies, with $232.31 received in 2024. These payments were reported across 172 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($3,338).
As a Medicare-enrolled provider, Anna has provided services to 5,509 Medicare beneficiaries, totaling 8,826 services with total Medicare billing of $420,439. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Foot & Ankle Surgery
- Other Specialties Foot & Ankle Surgery
- Location Augusta, GA
- Active Since 06/12/2006
- Last Updated 07/03/2019
- Taxonomy Code 213ES0103X
- Entity Type Individual
- NPI Number 1144262148
Products in Payments
- Kimyrsa (Drug) $238.84
- SIVEXTRO (Drug) $224.57
- DUEXIS (Drug) $201.66
- PENNSAID (Drug) $159.46
- RAYOS (Drug) $150.21
- Apligraf (Biological) $123.12
- LICART (Drug) $109.53
- Baxdela (Drug) $109.13
- Omnia (Device) $108.79
- DALVANCE (Drug) $91.57
- Puraply (Medical Supply) $84.83
- Stimrouter Implantable Kit (Device) $84.11
- Tirosint (Drug) $81.46
- COLLAGENASE SANTYL (Drug) $80.52
- LYRICA (Drug) $80.16
- Santyl (Drug) $78.87
- Licart (Drug) $78.32
- Simplicity (Device) $70.48
- VLP FOOT (Device) $68.14
- HYMOVIS (Device) $64.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Foot & Ankle Surgery Doctors in Augusta
Trevor Payne, D.p.m, D.P.M
Foot & Ankle Surgery — Payments: $7,535
Foot & Ankle Surgery $7,535
Brian Bennett, D.p.m, D.P.M
Foot & Ankle Surgery — Payments: $5,549
Foot & Ankle Surgery $5,549
Chanelle Duchaussee
Foot & Ankle Surgery — Payments: $1,728
Foot & Ankle Surgery $1,728
Dr. Francis Castillo, Dpm, DPM
Foot & Ankle Surgery — Payments: $1,485
Foot & Ankle Surgery $1,485
James Henry, Dpm, DPM
Foot & Ankle Surgery — Payments: $525.35
Foot & Ankle Surgery $525.35
Sakiyna Rose, Dpm, DPM
Foot & Ankle Surgery — Payments: $200.05
Foot & Ankle Surgery $200.05